Literature DB >> 9886737

Comparison of muscle volume between congenital and acquired superior oblique palsies by magnetic resonance imaging.

M Sato1, T Yagasaki, T Kora, S Awaya.   

Abstract

Magnetic resonance imaging (MRI) studies of superior oblique (SO) muscles have revealed a high incidence of SO muscle atrophy/hypoplasia in congenital SO palsy patients. It has also been reported that long-standing acquired SO palsy patients show atrophic SO muscles in the affected eye. The purpose of this study was to compare the incidence of SO muscle atrophy/hypoplasia in congenital and acquired SO palsy by utilizing MRI. Coronal MRI image planes were taken from 29 cases of unilateral congenital SO palsy and 9 cases of acquired unilateral SO palsy patients. The SO muscle bellies were traced and their sizes were measured from each image plane. The total volume of the affected superior oblique muscle was compared with that of the normal fellow eye. The mean volume of the affected superior oblique muscle to that of the normal muscle was 45.3% (SD = 30.1) in the congenital group and 65.8% (SD = 22.7) in the acquired group. The volume reduction of the SO muscle in congenital SO palsy patients appears to be mainly a congenital abnormality rather than a secondary change, as seen in acquired SO palsy patients.

Entities:  

Mesh:

Year:  1998        PMID: 9886737     DOI: 10.1016/s0021-5155(98)00044-6

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  11 in total

1.  Displacement of the rectus muscle pulleys simulating superior oblique palsy.

Authors:  Reika Kono; Hirotaka Okanobu; Hiroshi Ohtsuki; Joseph L Demer
Journal:  Jpn J Ophthalmol       Date:  2008-03-28       Impact factor: 2.447

2.  Superior oblique extraocular muscle shape in superior oblique palsy.

Authors:  Sun Young Shin; Joseph L Demer
Journal:  Am J Ophthalmol       Date:  2015-03-04       Impact factor: 5.258

3.  Predictive factors for corrective effect of inferior rectus recession for congenital superior oblique palsy.

Authors:  Manabu Miyata; Kiyo Shibata; Ichiro Hamasaki; Masayuki Hata; Yuki Muraoka; Munemitsu Yoshikawa; Satoshi Hasebe; Hiroshi Ohtsuki
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-11-07       Impact factor: 3.117

4.  Rectus Pulley Displacements without Abnormal Oblique Contractility Explain Strabismus in Superior Oblique Palsy.

Authors:  Soh Youn Suh; Alan Le; Robert A Clark; Joseph L Demer
Journal:  Ophthalmology       Date:  2016-03-13       Impact factor: 12.079

5.  Effects of intracranial trochlear neurectomy on the structure of the primate superior oblique muscle.

Authors:  Joseph L Demer; Vadims Poukens; Howard Ying; Xiaoyan Shan; Jing Tian; David S Zee
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-02-17       Impact factor: 4.799

6.  Vertical Comitance of Hypertropia in Congenital and Acquired Superior Oblique Palsy.

Authors:  Joseph L Demer
Journal:  J Neuroophthalmol       Date:  2021-10-08       Impact factor: 4.415

7.  Magnetic resonance imaging of the functional anatomy of the inferior rectus muscle in superior oblique muscle palsy.

Authors:  Li Jiang; Joseph L Demer
Journal:  Ophthalmology       Date:  2008-08-09       Impact factor: 12.079

8.  Absence of relationship between oblique muscle size and bielschowsky head tilt phenomenon in clinically diagnosed superior oblique palsy.

Authors:  Reika Kono; Hirotaka Okanobu; Hiroshi Ohtsuki; Joseph L Demer
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-09-12       Impact factor: 4.799

9.  High-resolution magnetic resonance imaging demonstrates reduced inferior oblique muscle size in isolated inferior oblique palsy.

Authors:  Noa Ela-Dalman; Federico G Velez; Joseph L Demer; Arthur L Rosenbaum
Journal:  J AAPOS       Date:  2008-10-04       Impact factor: 1.220

Review 10.  Fourth cranial nerve palsy and Brown syndrome: two interrelated congenital cranial dysinnervation disorders?

Authors:  Pierre-François Kaeser; Michael C Brodsky
Journal:  Curr Neurol Neurosci Rep       Date:  2013-06       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.